Finzati - Logo
PFE logo

Pfizer Inc.

PFE • Drug Manufacturers - General
$28.45
▼ -0.36 (-1.25%)
Current price
EarningsLatest report: Jun 28, 2026
BALANCED PROFILENeutralConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$162.14B
Growth
6.3%
Cash Flow
5/5
Trend
Stable
Evidence
Stable or improving margins · 12.4%Positive free cash flow · 1.6Consistent free cash flow · 5/5Reasonable earnings multiple · 18.21Manageable debt level · 0.78
Financial data as of: Jun 28, 2026, 12:00 AM UTCLast earnings update: Jun 28, 2026, 12:00 AM UTCLast profile update: Aug 6, 2026, 12:08 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$28.45
Change-1.25%
Shares Out5.70B
Market Cap$162.14B
Enterprise Value$213.63B
52W Range23.58 - 28.75
Beta0.31
P/E37.40
P/S2.55
P/B1.90
P/FCF14.76
EV/Sales3.35

Investment DNA

How strong this company looks for long-term investors

66
out of 100
Business Quality
Margins, moat, returns
71/100
Financial Strength
Debt, cash, stability
63/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
79/100
Why this score▼
Stable or improving margins · 12.4%Positive free cash flow · 1.6Consistent free cash flow · 5/5Reasonable earnings multiple · 18.21Manageable debt level · 0.78Negative growth trend

Analyst view

Analyst sentiment and price target

PFE
Analyst sentiment
Based on 39 analyst votes · 2026-09-05
68/100
Neutral
Bullish
15
Hold
23
Bearish
1
Price Target
2026-08-06
Low
$25.00
Mean
$26.88
Median
$27.00
High
$30.00

Company Overview

IPO: 6/1/1972
Industry: Drug Manufacturers - General
P/B i: 1.90
Debt / Equity i: 0.78
Operating Margin: 24.67%
Net Margin: 12.42%
ROE i: -
ROIC: -

Financial Health

Score13 / 20
Debt / Equity: 0.78
Current Ratio: 1.16
Quick Ratio: 0.87
Status: Good

Insider Transactions

Recent executive and insider activity

Buckley Mortimer J
Transaction: 08/05/2026
BUY
Change
+37,632
Price
$25.52
Filing
08/05/2026
Type
BUY
BLAYLOCK RONALD E
Transaction: 08/05/2026
BUY
Change
+39,231
Price
$25.46
Filing
08/05/2026
Type
BUY
BOURLA ALBERT
Transaction: 07/31/2026
BUY
Change
+24
Price
Not reported
Filing
08/03/2026
Type
BUY